F11R and cancer: Overexpressed on hematopoietic stem cells with in vivo repopulating activity6 and subsequently identified as a cancer stem-cell maintenance factor14, JAM-A may reprogram lymphoma cells to a de-differentiated stem-like state, contributing to lymphoma progression in DLBCL.